Inventor · disambiguated record
Irvin Mark Modlin
Also filed as: MODLIN IRVIN · MODLIN IRVIN M · MODLIN IRVIN MARK
11 granted patents·11 pending applications·8 citations·filing 2002–2025
83Inventor score
Files withLIQUID BIOPSY RES LLC15Clifton Life Sciences LLC3CL BioSciences LLC1UNIV ARIZONA1UNIV YALE1
Top patents by PatentIndex Score
22 records- 0187US10407730B2Compositions, methods and kits for diagnosis of a gastroenteropancreatic neuroendocrine neoplasmClifton Life Sciences LLC·Filed 2015·Granted Sep 10, 2019·4 cites·9 claims
- 0284US11168372B2Compositions, methods and kits for diagnosis of a gastroenteropancreatic neuroendocrine neoplasmClifton Life Sciences LLC·Filed 2019·Granted Nov 9, 2021·2 cites·18 claims
- 0380US11414707B2Methods for colon cancer detection and treatmentLIQUID BIOPSY RES LLC·Filed 2019·Granted Aug 16, 2022·1 cites·9 claims
- 0475US12305240B2Methods for colon cancer detection and treatmentLIQUID BIOPSY RES LLC·Filed 2022·Granted May 20, 2025·0 cites·12 claims
- 0575US2025327118A1Compositions, methods and kits for biological sample and rna stabilizationLIQUID BIOPSY RES LLC·Filed 2024·Application pending·0 cites
- 0674US12258633B2Compositions, methods and kits for diagnosis of a gastroenteropancreatic neuroendocrine neoplasmClifton Life Sciences LLC·Filed 2021·Granted Mar 25, 2025·0 cites·15 claims
- 0774US2024042069A1Predicting peptide receptor radiotherapy using a gene expression assayLIQUID BIOPSY RES LLC·Filed 2023·Application pending·0 cites
- 0872US2023298695A1Methods for prostate cancer detection and treatmentLIQUID BIOPSY RES LLC·Filed 2022·Application pending·0 cites
- 0972US2025243553A1Methods for colon cancer detection and treatmentLIQUID BIOPSY RES LLC·Filed 2025·Application pending·0 cites
- 1067US12399179B2Chemical compositions and methods of useLIQUID BIOPSY RES LLC·Filed 2021·Granted Aug 26, 2025·0 cites·17 claims
- 1167US12366575B2Chemical compositions and methods of useLIQUID BIOPSY RES LLC·Filed 2021·Granted Jul 22, 2025·0 cites·18 claims
- 1267US11410748B2Methods for prostate cancer detection and treatmentLIQUID BIOPSY RES LLC·Filed 2019·Granted Aug 9, 2022·0 cites·9 claims
- 1366US9988684B2Predicting gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs)UNIV YALE·Filed 2013·Granted Jun 5, 2018·1 cites·7 claims
- 1464US2025354219A1Methods for neuroendocrine cancer detection in salivaLIQUID BIOPSY RES LLC·Filed 2023·Application pending·0 cites
- 1564US2025354220A1Methods for prostate cancer detection in salivaLIQUID BIOPSY RES LLC·Filed 2023·Application pending·0 cites
- 1661US11744907B2Predicting peptide receptor radiotherapy using a gene expression assayLIQUID BIOPSY RES LLC·Filed 2018·Granted Sep 5, 2023·0 cites·11 claims
- 1759US2021108259A1Compositions, methods and kits for biological sample and rna stabilizationLIQUID BIOPSY RES LLC·Filed 2020·Application pending·0 cites
- 1858US2019025311A1Methods for detection of plasma cell dyscrasiaLIQUID BIOPSY RES LLC·Filed 2018·Application pending·0 cites
- 1957US2018340934A1Methods for melanoma detectionLIQUID BIOPSY RES LLC·Filed 2018·Application pending·0 cites
- 2052US2024277322A1Biofluid self-collection and processing deviceUNIV ARIZONA·Filed 2021·Application pending·0 cites
- 2147US2003175254A1Method of obtaining purified enterochromaffin cells and methods of using sameFiled 2002·Application pending·0 cites
- 2246US10709714B2Gastrin antagonists for treatment and prevention of osteoporosisCL BioSciences LLC·Filed 2014·Granted Jul 14, 2020·0 cites·26 claims
Join the waitlist — get patent alerts
Get an alert when Irvin Mark Modlin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →